Suven Life Sciences in demand on securing three product patents for NCEs

07 Feb 2012 Evaluate

Suven Life Sciences is currently trading at Rs. 16.50, up by 0.75 points or 4.76% from its previous closing of Rs. 15.75 on the BSE.

The scrip opened at Rs. 15.75 and has touched a high and low of Rs. 18.20 and Rs. 15.50 respectively. So far 395608 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 25.70 on 06-Apr-2011 and a 52 week low of Rs. 11.50 on 02-Jan-2012.

Last one week high and low of the scrip stood at Rs. 18.20 and Rs. 13.65 respectively. The current market cap of the company is Rs. 182.69 crore.

The promoters holding in the company stood at 63.44% while Institutions and Non-Institutions held 0.08% and 36.48% respectively.

Suven Life Sciences (Suven) has secured the grant of three product patents, two from USA and one from Mexico corresponding to the new chemical entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2025 and 2028.

The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (AND), Huntington's disease, Parkinson and Schizophrenia.

With these new patents, the company has a total of eleven granted patents from USA and twelve granted patents from Mexico. These granted patents are exclusive intellectual property of the company and are achieved through the internal discovery research efforts. The products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II.

Suven Life Sciences is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class therapies through the use of GPCR targets.

Suven Life Sciences Share Price

170.15 -1.25 (-0.73%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×